May 25, 2005 — The U.S. Food and Drug Administration and Serono, Inc., have notified healthcare professionals via letter of new information regarding the risks of cardiotoxicity and secondary acute ...

July 30, 2008 — The FDA has issued an alert informing healthcare professionals about additional recommendations for cardiac monitoring of patients with multiple sclerosis (MS) who are treated with ...

The US Food and Drug Administration and Swiss biotechnology company, Serono, have amended the product label for the latter's multiple sclerosis drug, Novantrone (mitoxantrone), to highlight a risk of ...

From 2009, interferon beta-1b has also been available from Novartis as Extavia; this is the same formulation as Betaferon. In addition to these, Amgens Novantrone (mitoxantrone) has been available to ...

A type of chemotherapy drug, called mitoxantrone, can potentially treat multiple sclerosis (MS) by suppressing blood cells that attack your myelin, the protective layer covering your brain and spinal ...

Learn everything you need to know about Mitoxantrone-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, ...

Mitoxantrone hydrochloride was the first FDA-approved medication for both secondary-progressive multiple sclerosis (MS) and progressive-relapsing MS. It’s also used to treat relapsing-remitting MS ...